In our study, we found that overexpression of TRIM22 promoted ESCC cell proliferation, migration, and invasion, which suggests that TRIM22 functions as an oncogenic driver in ESCC. This evidence concerns the gene TRIM22 and esophageal squamous cell carcinoma.